cover
ii
page 1 - Contents
page 2 - The sanofi-aventis Group profile
page 3 - Message from the Chairman
page 4
page 5
page 6
page 7
page 8
page 9
page 10 - Interview with the Chief Executive Officer
page 11
page 12
page 13
page 14 - 2009 milestones
page 15
page 16 - Corporate governance
page 17
page 18
page 19 - 2009 performance
page 20
page 21
page 22 - Strategy
page 23
page 24 - Reseach & Development: innovating for patients
page 25
page 26 - Building the future
page 27
page 28 - Industrail affairs: the power of global capacity
page 29 - Human ressources: rising to the challenge of growth
page 30 - Activities
page 31
page 32 - A robust and well-adapted model of growth
page 33
page 34 - Diabetes: from understandig to action
page 35 - Diversifying therapeutic approaches to cancer
page 36 - Pharmaceutical Customer Solutions: new therapeutic strategies
page 37 - Generics: a broad, well-adapted portfolio
page 38 - Human vaccines: addressing major public-health concerns
page 39
page 40 - Consumer Healthcare: a portfolio of leading global brands
page 41 - Animal health: a market with a future
page 42 - Responsibility
page 43
page 44 - A global agenda for corporate responsibility
page 45
page 46 - Rising to the challenge of providing more affordable medicines
page 47 - Humanitarian Partnerships: taking healthcare to the most needy
page 48
page 49
page 50
A-
A+
text color
default
white
blue
black
red
green
background-color
default
white
blue
black
red
green
contrast
80 chars max
default
contrast 1
contrast 2
default
page 16 - Corporate governance
CORPORATE GOVERNANCE
